<?xml version="1.0" encoding="iso-8859-1" ?>
<rss version="2.0" xmlns:s="http://resources.bnet.com/">
<channel>
	<title><![CDATA[Asco Plc. | Company News & Executive Profiles | BNET]]></title>
	<link><![CDATA[http://resources.bnet.com/topic/asco+plc..html?i=3]]></link>
	<description><![CDATA[Latest company news & analysis, recent events, stock quotes, earning call transcripts, with profiles and descriptions of top business executives for Asco Plc.]]></description>
	<s:counts start="0" returned="10" found="353" />
	<language>en-us</language>
	<item>
		<title><![CDATA[OSI Pharmaceuticals, Inc. Q2 2009 Earnings Call Transcript]]></title>
		<link><![CDATA[http://www.bnet.com/2462-14055_23-323859.html]]></link>
		<description><![CDATA[ Question-and-Answer Session Operator  (Operator instruction.) We&#8217;ll go first to Jeff Quinn with JP Morgan. Terry Bivens &#8211; JP Morgan  Hi guys, this is Terry in for Jeff Today. Just a question &#8211; I&#8217;m wondering where are you &#8211; if you can, can you update us on where...]]></description>
		<s:doctype><![CDATA[Earnings calls]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Wed, 22 Jul 2009 22:13:31 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/osi+pharmaceuticals+inc..html"><![CDATA[OSI Pharmaceuticals Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/marketing.html"><![CDATA[Marketing]]></category>
		<category domain="http://resources.bnet.com/topic/j.p.+morgan+chase+%2526+co..html"><![CDATA[J.P. Morgan Chase & Co.]]></category>
		<category domain="http://resources.bnet.com/topic/call+transcript.html"><![CDATA[Call Transcript]]></category>
		<category domain="http://resources.bnet.com/topic/asco+plc..html"><![CDATA[Asco Plc.]]></category>
		<category domain="http://resources.bnet.com/topic/earnings.html"><![CDATA[Earnings]]></category>
		<category domain="http://resources.bnet.com/topic/morgan+stanley.html"><![CDATA[Morgan Stanley]]></category>
		<category domain="http://resources.bnet.com/topic/analysis.html"><![CDATA[Analysis]]></category>
		<category domain="http://resources.bnet.com/topic/accrual.html"><![CDATA[Accrual]]></category>
		<category domain="http://resources.bnet.com/topic/terry.html"><![CDATA[Terry]]></category>
		<category domain="http://resources.bnet.com/topic/gabriel+leung+interim+analysis.html"><![CDATA[Gabriel Leung Interim Analysis]]></category>
		<category domain="http://resources.bnet.com/topic/sales+strategy.html"><![CDATA[Sales Strategy]]></category>
		<category domain="http://resources.bnet.com/topic/operational+accounting.html"><![CDATA[Operational Accounting]]></category>
		<category domain="http://resources.bnet.com/topic/sales+force+management.html"><![CDATA[Sales Force Management]]></category>
		<category domain="http://resources.bnet.com/topic/sales.html"><![CDATA[Sales]]></category>
		<category domain="http://resources.bnet.com/topic/finance.html"><![CDATA[Finance]]></category>
		<category domain="http://resources.bnet.com/topic/seeking+alpha.html"><![CDATA[Seeking Alpha]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">JPM</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">MS</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">OSIP</category>
		<category domain="tickers">JPM,MS,OSIP</category>
	</item>
	<item>
		<title><![CDATA[Exelixis, Inc. Q1 2009 Earnings Call Transcript]]></title>
		<link><![CDATA[http://www.bnet.com/2462-13071_23-300128.html]]></link>
		<description><![CDATA[ Question-and-Answer SessionOperator Operator instructions And your first question comes from the line of Edward Tenthoff of Piper Jaffray. Please proceed. Edward Tenthoff &#8211; Piper Jaffray Great, thank you very much. Just one quick clarification on Frank's comment on Boehringer upfront and congrats on that deal, guys. Will that be...]]></description>
		<s:doctype><![CDATA[Earnings calls]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Thu, 07 May 2009 19:31:15 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/patient.html"><![CDATA[Patient]]></category>
		<category domain="http://resources.bnet.com/topic/u.s.+bancorp+piper+jaffray+inc..html"><![CDATA[U.S. Bancorp Piper Jaffray Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/call+transcript.html"><![CDATA[Call Transcript]]></category>
		<category domain="http://resources.bnet.com/topic/asco+plc..html"><![CDATA[Asco Plc.]]></category>
		<category domain="http://resources.bnet.com/topic/earnings.html"><![CDATA[Earnings]]></category>
		<category domain="http://resources.bnet.com/topic/approval.html"><![CDATA[Approval]]></category>
		<category domain="http://resources.bnet.com/topic/exelixis+inc..html"><![CDATA[Exelixis Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/gbm.html"><![CDATA[GBM]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://resources.bnet.com/topic/seeking+alpha.html"><![CDATA[Seeking Alpha]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">EXEL</category>
		<category domain="tickers">EXEL</category>
	</item>
	<item>
		<title><![CDATA[Tests Could Predict Benefit From Cancer Drugs]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_kmhea/is_200810/ai_n30942277]]></link>
		<description><![CDATA[What if a blood test or biopsy could predict if a cancer therapy will help cure you, or only make you feel worse? Tests like these, based on genes, proteins or other "molecular markers" may someday do just that for people battling colon, lung and pancreatic tumors, scientists reported at...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Wed, 29 Oct 2008 23:59:59 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/asco+plc..html"><![CDATA[Asco Plc.]]></category>
		<category domain="http://resources.bnet.com/topic/kras+d.d..html"><![CDATA[Kras d.d.]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
	<item>
		<title><![CDATA[ImmunoGen, Inc. Announces Presentation of Encouraging Clinical Findings with Trastuzumab-DM1 at ASCO]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2008_June_3/ai_n25473333]]></link>
		<description><![CDATA[WALTHAM, Mass. -- ImmunoGen, Inc. (Nasdaq: IMGN) announced today the presentation of encouraging clinical findings with trastuzumab-DM1 (T-DM1) at the 2008 American Society of Clinical Oncology ASCO Annual Meeting taking place in Chicago, IL. T-DM1 comprises ImmunoGen's DM1 cell-killing agent linked to Genentech's HER2-targeting antibody, trastuzumab. Genentech is developing T-DM1...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Tue, 03 Jun 2008 00:00:00 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/asco+plc..html"><![CDATA[Asco Plc.]]></category>
		<category domain="http://resources.bnet.com/topic/genentech+inc..html"><![CDATA[Genentech Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/company.html"><![CDATA[Company]]></category>
		<category domain="http://resources.bnet.com/topic/immunogen+inc..html"><![CDATA[ImmunoGen Inc.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">DNA</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">IMGN</category>
		<category domain="tickers">DNA,IMGN</category>
	</item>
	<item>
		<title><![CDATA[New Data from Several Satraplatin Clinical Trials in Solid Tumors Presented at 44th ASCO Annual Meeting]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2008_June_2/ai_n25470659]]></link>
		<description><![CDATA[MARTINSRIED/MUNICH, Germany & PRINCETON, N.J. -- GPC Biotech AG (Frankfurt Stock Exchange: GPC, NASDAQ: GPCB) today announced the presentation of data from several satraplatin clinical trials at the 44th Annual Meeting of the American Society for Clinical Oncology ASCO in Chicago.  "We are pleased that data from several satraplatin...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Mon, 02 Jun 2008 23:59:59 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/asco+plc..html"><![CDATA[Asco Plc.]]></category>
		<category domain="http://resources.bnet.com/topic/company.html"><![CDATA[Company]]></category>
		<category domain="http://resources.bnet.com/topic/gpc+biotech+ag.html"><![CDATA[GPC Biotech AG]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">GPCB</category>
		<category domain="tickers">GPCB</category>
	</item>
	<item>
		<title><![CDATA[Data from Satraplatin SPARC Phase 3 Trial in Patients with Hormone-Refractory Prostate Cancer Progressing after Initial Chemotherapy Presented at 44th ASCO Annual Meeting]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2008_June_2/ai_n25470660]]></link>
		<description><![CDATA[MARTINSRIED/MUNICH, Germany & PRINCETON, N.J. -- GPC Biotech AG (Frankfurt Stock Exchange: GPC, NASDAQ: GPCB) today announced the presentation of the overall survival results from the double-blind, randomized satraplatin Phase 3 registrational trial, the SPARC trial Satraplatin and Prednisone Against Refractory Cancer. The data were presented at the 44th Annual...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Mon, 02 Jun 2008 23:59:59 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/asco+plc..html"><![CDATA[Asco Plc.]]></category>
		<category domain="http://resources.bnet.com/topic/company.html"><![CDATA[Company]]></category>
		<category domain="http://resources.bnet.com/topic/gpc+biotech+ag.html"><![CDATA[GPC Biotech AG]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">GPCB</category>
		<category domain="tickers">GPCB</category>
	</item>
	<item>
		<title><![CDATA[TransMolecular Reports Positive Results from Phase 1 Trial of Iodine-TM601 in Metastatic Melanoma]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2008_June_2/ai_n25470814]]></link>
		<description><![CDATA[- ASCO abstract re-confirms that intravenous radiolabeled TM601 can cross the blood-brain barrier and bind to tumor tissue-  CAMBRIDGE, Mass. -- TransMolecular, Inc., a biotechnology company focused on targeted therapies for cancer, today announced positive interim Phase 1 data for its intravenous formulation of 131I-TM601 in metastatic melanoma in...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Mon, 02 Jun 2008 23:59:59 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/asco+plc..html"><![CDATA[Asco Plc.]]></category>
		<category domain="http://resources.bnet.com/topic/company.html"><![CDATA[Company]]></category>
		<category domain="http://resources.bnet.com/topic/transmolecular+inc..html"><![CDATA[TransMolecular Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
	<item>
		<title><![CDATA[Geron Presentations at the ASCO 2008 Annual Meeting]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2008_June_2/ai_n25470921]]></link>
		<description><![CDATA[New Data on Activity of GRN163L in T-cell Prolymphocytic Leukemia Cells  MENLO PARK, Calif. -- Geron Corporation (Nasdaq:GERN) today announced two presentations of its anti-cancer drug, GRN163L, given at the American Society of Clinical Oncology ASCO annual meeting in Chicago.  Geron is currently testing GRN163L in four clinical...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Mon, 02 Jun 2008 23:59:59 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/asco+plc..html"><![CDATA[Asco Plc.]]></category>
		<category domain="http://resources.bnet.com/topic/geron+corp..html"><![CDATA[Geron Corp.]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">GERN</category>
		<category domain="tickers">GERN</category>
	</item>
	<item>
		<title><![CDATA[Gloucester Pharmaceuticals Announces Presentation of Romidepsin Phase 1 Data in Multiple Solid Tumors at ASCO]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2008_June_2/ai_n25470954]]></link>
		<description><![CDATA[Romidepsin/Gemcitabine Combination Warrants Further Exploration  CAMBRIDGE, Mass. -- Gloucester Pharmaceuticals today announced results from a Phase 1 study of romidepsin in combination with gemcitabine in patients with solid tumors. The results from the Phase 1 study showed that the combination was generally well tolerated and indicated that further investigation...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Mon, 02 Jun 2008 23:59:59 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/asco+plc..html"><![CDATA[Asco Plc.]]></category>
		<category domain="http://resources.bnet.com/topic/company.html"><![CDATA[Company]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
	<item>
		<title><![CDATA[Ipsen and Spirogen's SJG-136 Shows Encouraging Results in the Treatment of Refractory Solid Tumours At ASCO]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2008_June_2/ai_n25471262]]></link>
		<description><![CDATA[PARIS & LONDON -- Regulatory News:  Ipsen (Paris:IPN) (Euronext: IPN) and Spirogen Ltd. announced today that final results from a Phase I clinical trial of the DNA sequence recognizing minor groove binder SJG-136 sponsored by the US National Cancer Institute NCI under a Cooperative Research and Development Agreement CRADA...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Mon, 02 Jun 2008 23:59:59 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/asco+plc..html"><![CDATA[Asco Plc.]]></category>
		<category domain="http://resources.bnet.com/topic/spirogen+ltd..html"><![CDATA[Spirogen Ltd.]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
</channel>
</rss>
